RecruitingNCT01209000
Nephrotic Syndrome Study Network
Studying Nephrotic syndrome without extrarenal manifestations
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Michigan
- Principal Investigator
- Matthias Kretzler, MDUniversity of Michigan
- Intervention
- Kidney Biopsy(procedure)
- Enrollment
- 1200 enrolled
- Eligibility
- 80 years · All sexes
- Timeline
- 2010 – 2029
Study locations (30)
- University of Southern California-Children's Hospital, Los Angeles, California, United States
- Stanford University School of Medicine, Palo Alto, California, United States
- University of California San Francisco Benioff Children's Hospitals, San Francisco, California, United States
- Lundquist Biomedical Research Institute at Harbor UCLA Medical Center, Torrance, California, United States
- Children's Hospital Colorado, Aurora, Colorado, United States
- University of Colorado Anschutz School of Medicine, Aurora, Colorado, United States
- University of Miami Miller School of Medicine, Miami, Florida, United States
- Emory University and Children's Healthcare of Atlanta, Atlanta, Georgia, United States
- John Stroger Cook County Hospital, Chicago, Illinois, United States
- University of Kansas Medical Center, Kansas City, Kansas, United States
- Johns Hopkins Medical Institute, Baltimore, Maryland, United States
- Kidney Disease Section, NIDDK, NIH, Bethesda, Maryland, United States
- CS Mott Children's Hospital, University of Michigan, Ann Arbor, Michigan, United States
- University of Michigan Medical Center, Ann Arbor, Michigan, United States
- Mayo Clinic, Rochester, Minnesota, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · The NephCure Foundation
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01209000 on ClinicalTrials.govOther trials for Nephrotic syndrome without extrarenal manifestations
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1NCT07267026A Study to Evaluate the Safety, Tolerability and PK of SK-09Consun Pharmaceutical Group
- RECRUITINGPHASE4NCT07219121Sparsentan in Posttransplant Immunoglobulin A Nephropathy or Focal Segmental GlomerulosclerosisTravere Therapeutics, Inc.
- RECRUITINGNANCT06867471Effects of Exogenous Ketosis on Proteinuria and Renal FunctionGødstrup Hospital
- RECRUITINGPHASE3NCT05716880Ketoanalogues for Muscle Mass Loss in Nephrotic SyndromeMilitary Institute od Medicine National Research Institute
- RECRUITINGPHASE2NCT05003986Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular DiseasesTravere Therapeutics, Inc.
- RECRUITINGNCT01094327Proteinuria in Pre and Post TransplantUniversity of Miami
See all trials for Nephrotic syndrome without extrarenal manifestations →